Romano Brothers & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
Romano Brothers & Co's ABBV Position: Q2 2026 in Review
Romano Brothers & Co reduced its AbbVie (ABBV) stake by 1.8% in Q2 2026, selling an estimated $488K and leaving 123,458 shares worth $31.1M. The position accounts for 3.12% of the portfolio, ranked #2.
Romano Brothers & Co first reported a position in ABBV in Q3 2022 and has held it in 16 quarters since. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Romano Brothers & Co held 123,458 shares of AbbVie worth $31.1M as of Q2 2026.
- Romano Brothers & Co sold 2,268 AbbVie shares in Q2 2026, an estimated $488K.
- AbbVie made up 3.12% of Romano Brothers & Co's portfolio in Q2 2026, its #2 holding.
- Romano Brothers & Co first reported a position in AbbVie in Q3 2022 and has held it in 16 quarters since.
- 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Romano Brothers & Co's 13F filing for Q2 2026, filed 22 Jul 2026.